Germany’s Pro Generika Sees Steep Revlimid Savings
Lenalidomide Prices Drop By Up To 60% With 17 Generics On The Market
Executive Summary
Generic lenalidomide competitors to BMS’ Revlimid brand have brought the cost of the cancer drug down by as much as 60% in Germany just a couple of months after launch, according to local generics association Pro Generika. However, the industry body has warned, price pressure must not grow so pronounced that the generics market becomes unsustainable.